The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
When will this stop going up!?
11% up today almost 3 times on the year. Everyone needs their MyID product - will grow and grow.
This closely this morning... It appears she has an upward tick with nearly every buy! What a excellent Rns! GLA!
Fab statement!!
From today's RNS: "The Group's financial targets were to deliver a 30%+ increase in sales whilst accelerating investment in people and resources to take advantage of the opportunities provided by the impact of smart phones and global cyber security concerns. Following a strong end to the year, pre-audit indications are that revenues will be ahead of expectations and in excess of 40% higher than the prior year as Intercede continues to experience high levels of demand for its proprietary MyID identity and credential management technology, with notable contract wins secured in the telecommunications, aerospace & defence and public service sectors. Cash performance also continues to be strong with an increase in net cash from £6.8 million to £7.2 million year on year, notwithstanding a 30% increase in headcount and the impact of the recently announced share buyback programme in support of the new Intercede Share Incentive Plan."
yep top top company this. year low of 60s too..great rise.
nearly at 200p
Intercede Group plc : Intercede shortlisted for UK’s Most Innovative Mobile Company award 01/10/2014 | 03:37am US/EasternRecommend: 0 Market-leading identity and credential management company Intercede has been shortlisted for the SmartUK Project award for Most Innovative Mobile Company. The award takes in British innovation from diverse solutions in a wide range of industries, with the winner receiving their award at Mobile World Congress 2014. Operated in association with UKTI, the SmartUK award is judged by a panel of mobile industry experts who will consider the potential, relevancy and impact of entries. Intercede's entry is based on its MyID software, which enables the creation, use and management of trusted credentials bound to a verified identity, which can be used for strong authentication to access corporate systems, networks, information and facilities, from anywhere, on any mobile device. The company will be showcasing MyID at Mobile World Congress 2014, where Chief Technical Officer Chris Edwards will also be discussing "Secure mobile credentials as the cornerstone of trusted identity frameworks" on Feb 27 at 2.30pm.
IGP - Intercede (AIM: IGP.L) is a leading producer of Identity and Credential Management software, called MyID, which manages the secure registration, issuance and life cycle of digital identities for a wide range of uses. from last results: "I believe 2014 will be an inflexion year for the adoption of Intercede's technology by mainstream channel partners and large customers. This underpins our focus on building a business and technology platform to deliver our previously declared high growth 2020 vision. We remain confident that this strategy will maximise long term shareholder value." from final results prior: The Group has no debt and, following the 2010 Capital Reduction, is in a position to be able to commence the payment of dividends as and when the Board considers this to be appropriate.
Interesting!
A major contract win......more to be announced...This is going to be huge and is a very strong buy....
A high growth company. Will shoot up very rapidly and one to top up during volatility...BUY..
55p in April - 130p today.
On the ft website there is a mention of the director deals at igp
At last some movement before the AGM
Three new contracts since the year end with revenue of £3.5m in this year and significant future revenue expected after that. Compared to last years t/o of £6.7m and with gross margins last year of 99%+ surely this year should be massive.
Extracts from full year results: "Intercede currently has 7 million digital identities actively managed by its MyID software. In my Chairman's Statement last year I stated that Intercede's Vision is to have more than 100 million identities under management by 2020. The Vision anticipates a 20-fold increase in volume from the 2012 base financial year will yield a 10-fold increase in revenue against a much smaller increase in the cost base. This is a very attractive business model." "Expenditure on research and development (R&D) activities totalled £2,328,000 (2012: £2,071,000). In accordance with IFRS, the Board has continued to determine that all internal R&D costs incurred in the year are expensed. No development expenditure has been capitalised as at 31 March 2013 (2012: £nil)." "In the year ended 31 March 2013, revenue decreased by 3% from £6,964,000 to £6,727,000 at a gross margin of 99.6% (2012: 98.4%)." "Large scale homeland security project awarded by a multinational prime contractor on behalf of a government agency in a G8 Nation; an initial order for £0.6m received April 2013 with a contract value likely to exceed £1.5m in the year ended 31 March 2014 and £10.0m over a five year period." "Cash balances of £6.8m remain strong at 31 March 2013 (2012: £7.0m)."
These often take longer than you hope, but these are big numbers and hopefully the first of many similar deals.
Smashed it!!!
Intercede is pleased to announce the appointment of Ian Ashley Drew as a non-executive director with immediate effect. Ian Drew, age 47, is currently Executive Vice President of Marketing and Business Development for ARM Holdings plc. He joined ARM in July 2005 as VP Segment Marketing and has been a member of the Executive Committee since July 2008. Prior to this, he worked at Intel Corporation for 14 years in various senior management roles in Asia, Europe and the US; latterly as GM of the Russia/CIS office based in Moscow. Ian is also ARM's shareholder director at Trustonic, a joint venture company between ARM, Gemalto and G&D. The Trustonic vision is "To be the trusted foundation of choice for all smart connected devices".
Cash balances were expected to remain above £6.0m.
Cyber security company Intercede Group said delays in US orders could result in an operating loss for the year. Shares fell 16.78% to 62.00p as the group said uncertainty surrounding the US budget impacted sales to government departments and defence contractors. "While Intercede had previously expected this uncertainty to be resolved in December 2012, President Obama's compromise agreement with Congress on the 'fiscal cliff' has delayed any decision on spending cuts until at least the end of February 2013," the company said in a statement. The fiscal issues have caused the deferral of new orders in the company's next financial period. Intercede, which also supplies to businesses in the UK and Europe, relies heavily on the US market for revenues so it could prove to have a material adverse impact on results. "Given the extent of our planned investment in organic growth, this would result in an operating loss for the year," Intercede stated.
Producer of credit management software Intercede Group (IGP) has reported a loss before tax of 185,000 pounds for the six months ended 30th September, a swing from a profit of 653,000 pounds last year. The company attribute this turnaround from profit to loss to its investment programme, embarked on in an attempt to accelerate the growth of the business. The shares were down by 2.5p to 69p.
"First half trading was in line with expectations and we anticipate several new contracts will begin generating revenue in the second half of the year."